Paper326386
Current status of estrogen and progesterone receptors in breast cancer.
McGuire WL and 3 others. Cancer, 1977. Cited by 443 papers, by iCite.
Cite this record
ConductScience Library. Current status of estrogen and progesterone receptors in breast cancer. Papers, record 326386. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326386
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Receptors, Estrogen | Major topic |
| Receptors, Progesterone | Major topic |
| Adrenalectomy | |
| Androgens | |
| Animals | |
| Castration | |
| Estrogen Antagonists | |
| Estrogens | |
| Female | |
| Glucocorticoids | |
| Humans | |
| Hypophysectomy | |
| Mammary Neoplasms, Experimental | |
| Menopause | |
| Progesterone | |
| Progesterone Congeners | |
| Rats | |
| Receptors, Androgen | |
| Receptors, Glucocorticoid |
Source PubMed
Cited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 443 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41898640 | Dexamethasone Suppresses Already Low Estrogen Receptor Levels in Meningiomas. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898640 | PubMed |
| 39460487 | Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor-Associated Immune Cell Signatures and Immuno Nano Sensors. | Small | 2024 | https://conductscience.org/library/papers/39460487 | PubMed |
| 36979610 | Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers. | Biosensors (Basel) | 2023 | https://conductscience.org/library/papers/36979610 | PubMed |
| 36358871 | CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358871 | PubMed |
| 35666660 | Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer at a Single Cancer Center. | Oncologist | 2022 | https://conductscience.org/library/papers/35666660 | PubMed |
| 34364700 | Landmark trials in the medical oncology management of metastatic breast cancer. | Semin Oncol | 2021 | https://conductscience.org/library/papers/34364700 | PubMed |
| 33475288 | Epidemiology of Triple-Negative Breast Cancer: A Review. | Cancer J | 2021 | https://conductscience.org/library/papers/33475288 | PubMed |
| 32718075 | PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32718075 | PubMed |
| 32485679 | 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future. | J Mol Endocrinol | 2020 | https://conductscience.org/library/papers/32485679 | PubMed |
| 32229068 | The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review. | Nucl Med Biol | 2021 | https://conductscience.org/library/papers/32229068 | PubMed |
| 31959227 | Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype. | Clin Epigenetics | 2020 | https://conductscience.org/library/papers/31959227 | PubMed |
| 31016232 | Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol. | NPJ Breast Cancer | 2019 | https://conductscience.org/library/papers/31016232 | PubMed |
| 30763392 | Discrimination of breast cancer from benign tumours using Raman spectroscopy. | PLoS One | 2019 | https://conductscience.org/library/papers/30763392 | PubMed |
| 30167331 | CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion. | ESMO Open | 2018 | https://conductscience.org/library/papers/30167331 | PubMed |
| 29146555 | Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. | Mol Cell Endocrinol | 2018 | https://conductscience.org/library/papers/29146555 | PubMed |
| 28173783 | Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28173783 | PubMed |
| 28000875 | Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression. | Oncol Rep | 2017 | https://conductscience.org/library/papers/28000875 | PubMed |
| 26309407 | A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor Cells. | Breast Cancer (Auckl) | 2015 | https://conductscience.org/library/papers/26309407 | PubMed |
| 26146614 | The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26146614 | PubMed |
| 25565869 | Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature. | Onco Targets Ther | 2015 | https://conductscience.org/library/papers/25565869 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/326386
GET https://conductscience.org/api/papers/v1/326386/cited_by?page=2